Literature DB >> 12956914

Objective assessment of nasal resistance in patients with nasal disease.

A H Suzina1, M Hamzah, A R Samsudin.   

Abstract

Nasal obstruction is a subjective complaint in patients with nasal disease. The ability to quantitate the nasal ventilation dysfunction would be useful for making the appropriate choice of nasal disease management. This cross-sectional study comprised of 200 adult subjects. They underwent assessment of relevant symptoms, nasal examination and investigations before undergoing active anterior rhinomanometry (AAR) assessment. A group of 88 normal subjects and 112 patients with nasal disease were included. The mean total nasal air resistance (NAR) was significantly higher in patients with nasal disease (0.33 Pa/cm(3)/s) as compared to normal subjects (0.24 Pa/cm(3)/s). There was no significant difference in total NAR between patients with symptoms of nasal obstruction and those without the symptoms (p = 0.42). It is concluded that AAR is a sensitive but not a specific tool for the detection of abnormalities in NAR and it failed to relate to the symptom of nasal obstruction.

Entities:  

Mesh:

Year:  2003        PMID: 12956914     DOI: 10.1258/002221503768199933

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  3 in total

1.  Intra-oral low level laser therapy in chronic maxillary sinusitis: A new and effective recommended technique.

Authors:  Hamed Mortazavi; Hamidreza Khalighi; Ali Goljanian; Robab Noormohammadi; Saeed Mojahedi; Siamak Sabour
Journal:  J Clin Exp Dent       Date:  2015-12-01

2.  Comparison of the effects of spreader graft and overlapping lateral crural technique on rhinoplasty by rhinomanometry.

Authors:  Mahmoud Omranifard; Hosein Abdali; Mehdi Rasti Ardakani; Amiryousef Ahmadnia
Journal:  World J Plast Surg       Date:  2013-06

3.  Three-Dimensional Measurements in Assessing the Results of Inferior Turbinate Surgery.

Authors:  Olli Valtonen; Jaakko Ormiskangas; Teemu Harju; Markus Rautiainen; Ilkka Kivekäs
Journal:  Ann Otol Rhinol Laryngol       Date:  2021-07-01       Impact factor: 1.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.